← Back to news
S

Seeking Alpha: News

Park-Ohio beats top-line estimates; reaffirms FY26 outlook

S

Acushnet Holdings Corp. declares $0.255 dividend

S

RGC Resources GAAP EPS of $0.84 beats by $0.06, revenue of $45.46M beats by $7.26M

S

Kraft Heinz launches $1.1B tender offer for 2046 and 2049 senior notes

S

TScan Therapeutics GAAP EPS of -$0.22 misses by $0.01, revenue of $1M misses by $1.5M

S

Weis Markets GAAP EPS of $1.13, revenue of $1.26B

S

France trade balance deteriorates in Q1

S

KVH GAAP EPS of $0.03 misses by $0.01, revenue of $32.3M misses by $1.94M

S

White Mountains Insurance GAAP EPS of -$12.59, revenue of $517.8M

S

Blue Owl Capital cuts quarterly dividend 16% amid lower rates, spread compression

S

Iran reviews one-page proposal to end war with U.S. - report

S

A.P. Møller - Mærsk A/S GAAP EPS of $4.00, revenue of $12.97B; reaffirms FY26 outlook

B

Pursuit reaffirms $123M-$133M 2026 adjusted EBITDA as FlyOver sale is expected to close in May

B

Shell in charts: Q1 revenue from integrated gas, upstream falls, renewables rise

B

Biote maintains 2026 outlook above $190M revenue as it targets restoring Asteria supply by end of Q2

B

Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1B

B

Vonovia SE Non-GAAP EPS of €0.43, revenue of €1.26B; reaffirms FY26 outlook

B

Sera projects cash runway through 2029 while targeting nearly $10M annual operating expense reduction

B

Tutor Perini outlines 2026 adjusted EPS of $4.90-$5.30 while expecting double-digit revenue growth

S

Shell reports mixed Q1 results; gives Q2 and updates FY26 outlook

S

Tamarack Valley Energy Non-GAAP EPS of $0.20, revenue of $443.94M; reaffirms FY26 outlook

S

Siemens Healthineers AG reports Q2 results

S

Paycom reaffirms 2026 revenue of $2.175B-$2.195B and adjusted EBITDA of $950M-$970M while board approves new $2B buyback

S

Perma-Fix Environmental Services GAAP EPS of -$0.40 misses by $0.32, revenue of $11.13M misses by $6.97M

S

Immunocore GAAP EPS of $0.25 beats by $0.47, revenue of $106.68M misses by $3.7M

S

Lundin Gold GAAP EPS of $1.13, revenue of $567.38M misses by $9.92M; on track to meet production guidance

S

Root GAAP EPS of $2.09 beats by $1.25, revenue of $393.5M misses by $1.25M

S

India's Zee sues Reliance-Disney over alleged music copyright breach, Reuters reports

S

Macerich targets 88%-89% physical permanent occupancy through Path Forward plan as it expects at least 3% 2026 go-forward NOI growth

B

Asia markets surge, Japan hits records on Middle East peace hopes and tech gains

B

Viridian Therapeutics prices upsized $350M concurrent stock, and convertible notes offerings

B

CDC monitoring U.S. travelers aboard cruise ship hit by hantavirus outbreak

B

Cytokinetics prices upsized $700M equity raise at $71 per share

S

Materialise GAAP EPS of €0.03, revenue of €66.28M; reaffirms FY26 outlook

S

Tenaris names veteran Gabriel Podskubka as CEO

S

argenx SE GAAP EPS of $5.52 beats by $0.31, revenue of $1.3B misses by $10M

S

NFT announces 1-for-80 reverse share split

S

Cactus Non-GAAP EPS of $0.70 beats by $0.03, revenue of $388.3M beats by $7.53M

S

Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes

S

IRSA Inversiones y Representaciones Sociedad Anónima GAAP EPS of ARS 283.71, revenue of ARS 464.37B

S

CK Hutchison weighs further telecom asset sales after $5.8B UK exit: report

S

McEwen Mining beats top-line and bottom-line estimates; reaffirms FY26 outlook

S

BlackRock Asia private credit fund at test after China loan turns sour - report

S

Fortuna Silver Mines reports mixed Q1 results; on track to deliver 2026 production guidance

S

Denarius Metals drops pursuit of Emerita Resources acquisition talks

S

Torex Gold Resources Non-GAAP EPS of $2.08, revenue of $539.3M beats by $9.32M; on track to achieve annual production guidance

S

Chime forecasts $2.66B-$2.69B FY2026 revenue as it authorizes $200M buyback and expands Chime Prime

S

Honest signals 4% to 6% organic revenue growth in 2026 while reaffirming $20M to $23M adjusted EBITDA

S

Arcutis outlines $480M-$495M 2026 revenue guidance while expanding ZORYVE sales teams

S

X4 Pharmaceuticals GAAP EPS of -$0.16 beats by $0.04, revenue of $2.71M beats by $0.88M

S